Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients, 18-80 years of age;
drug naive patients with type 2 diabetes uncontrolled with diet and exercise;
tested negative for anti-glutamic acid decarboxylase (anti-GAD) antibodies;
C-peptide (fasting) \>=1.0ng/mL
HbA1c \>=6.5% and \<=10.0% at screening;
BMI \>=25 (\>23 for Asians) and \<=45kg/m2 at screening;
stable weight +/- 5% for at least 12 weeks prior to screening.
You may not be if
history of type 1 diabetes mellitus or acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma in the previous 6 months;
evidence of clinically significant diabetic complications;
symptomatic poorly controlled diabetes;
myocardial infarction, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within the previous 6 months;
known hemoglobinopathy or chronic anemia.
Clareo Health | A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
